Pediatric Neuropsychiatric Syndromes: Updates on COVID-19 Infection and Vaccination
Journal of Child and Adolescent Psychopharmacology · 2025
DOI: 10.1089/cap.2024.0129 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Child and Adolescent Psychopharmacology, 2025. Verfasst von Sarah O'Dor und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA. Hauptthemen laut MEDLINE: COVID-19, Vaccination, COVID-19 Vaccines, Streptococcal Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.
- Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
- Pediatric Research and Advocacy Initiative, Richmond, Virginia, USA.
- Department of Environmental & Occupational Health Sciences, University of Washington, Seattle, WA, USA.
ORCID-Profile: Sarah O'Dor
Zitieren
APA
O'Dor, S., Adams, C., Gavin, J., Zagaroli, J. S., Carlisle, E., Downer, O. M., Williams, K. A., & Masterson, E. E. (2025). Pediatric Neuropsychiatric Syndromes: Updates on COVID-19 Infection and Vaccination. Journal of Child and Adolescent Psychopharmacology. https://doi.org/10.1089/cap.2024.0129
Vancouver
O'Dor S, Adams C, Gavin J, Zagaroli JS, Carlisle E, Downer OM, et al. Pediatric Neuropsychiatric Syndromes: Updates on COVID-19 Infection and Vaccination. Journal of Child and Adolescent Psychopharmacology. 2025. doi:10.1089/cap.2024.0129
BibTeX
@article{ODor2025,
author = {O'Dor, Sarah and Adams, Celia and Gavin, Jessica and Zagaroli, Julia S and Carlisle, Elliott and Downer, Olivia M and Williams, Kyle A and Masterson, Erin E},
title = {Pediatric Neuropsychiatric Syndromes: Updates on COVID-19 Infection and Vaccination},
journal = {Journal of Child and Adolescent Psychopharmacology},
year = {2025},
doi = {10.1089/cap.2024.0129}
}
EUVIMED